Last reviewed · How we verify
AZD5312
At a glance
| Generic name | AZD5312 |
|---|---|
| Also known as | ISIS 560131 |
| Sponsor | AstraZeneca |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate Cancer (PHASE1)
- Phase I Open Label Dose Escalation Study to Investigate the Safety & Pharmacokinetics of AZD5312 in Patients With Androgen Receptor Tumors (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |